In vitro differentiation of bone marrow derived porcine mesenchymal stem cells to endothelial cells

Journal of Tissue Engineering and Regenerative Medicine

Volumn 7, Issue 11, 2013, Pages 911-920

  Pankajakshan, Divya ^a   Kansal, Vikash ^a   Agrawal, Devendra K ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Endothelial cells; Mesenchymal stem cells; Re endothelialization; Tisuue engineering; VEGF

Indexed keywords

BONE; CELL ENGINEERING; ENDOTHELIAL CELLS; FLOWCHARTING; GLYCOPROTEINS; POLYMERASE CHAIN REACTION; STEM CELLS; TISSUE REGENERATION;

BONE MARROW; ENDOTHELIAL GROWTH; ENDOTHELIAL-CELLS; ENDOTHELIALIZATION; GROWTH MEDIUM; IN-VITRO; MESENCHYMAL STEM CELL; RE-ENDOTHELIALIZATION; TISUUE ENGINEERING; VEGF;

CELL CULTURE;

CD31 ANTIGEN; ENDOTHELIAL CELL GROWTH FACTOR; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL ASSAY; CELL DIFFERENTIATION; CELL LINEAGE; CONTROLLED STUDY; ENDOTHELIUM CELL; FLOW CYTOMETRY; IN VITRO STUDY; MESENCHYME CELL; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SWINE; TISSUE ENGINEERING;

ENDOTHELIAL CELLS; MESENCHYMAL STEM CELLS; RE-ENDOTHELIALIZATION; TISUUE ENGINEERING; VEGF;

ANIMALS; BIOLOGICAL MARKERS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL LINEAGE; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; IMMUNOPHENOTYPING; MESENCHYMAL STROMAL CELLS; NEOVASCULARIZATION, PHYSIOLOGIC; REAL-TIME POLYMERASE CHAIN REACTION; SUS SCROFA;

EID: 84887146361     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.1483     Document Type: Article

References (27)

1. Asahara T, Murohara T, Sullivan A, et al. 1997; Isolation of putative progenitor endothelial cells for angiogenesis. Science 275: 964-967.
2. De Val S, Black BL. 2009; Transcriptional control of endothelial cell development. Dev Cell 16: 180-195.
3. Dominici M, Le Blanc K, Mueller I, et al. 2006; Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8: 315-317.
4. Ferrara N, Carver-Moore K, Chen H, et al. 1996; Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380: 439-442.
5. Fong GH, Rossant J, Gertsenstein M, et al. 1995; Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376: 66-70.
6. Ghannam S, Bouffi C, Djouad F, et al. 2010; Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications. Stem Cell Res Ther 1: 2.
7. Jiang Y, Jahagirdar BN, Reinhardt RL, et al. 2002; Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418: 41-49.
8. Kaufman DS, Lewis RL, Hanson ET, et al. 2004; Functional endothelial cells derived from rhesus monkey embryonic stem cells. Blood 103: 1325-1332.
9. Kuo TK, Hung SP, Chuang CH, et al. 2008; Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells. Gastroenterology 134: 2111-2121, el2121-2123.
10. Lampugnani MG, Resnati M, Raiteri M, et al. 1992; A novel endothelial-specific membrane protein is a marker of cell-cell contacts. J Cell Biol 118: 1511-1522.
11. Lee OK, Kuo TK, Chen WM, et al. 2004; Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 103: 1669-1675.
12. Levenberg S, Golub JS, Amit M, et al. 2002; Endothelial cells derived from human embryonic stem cells. Proc Natl Acad Sci USA 99: 4391-4396.
13. Mannucci PM, Federici AB. 1995; Antibodies to von Willebrand factor in von Willebrand disease. Adv Exp Med Biol 386: 87-92.
14. McCloskey KE, Lyons I, Rao RR, et al. 2003; Purified and proliferating endothelial cells derived and expanded in vitro from embryonic stem cells. Endothelium 10: 329-336.
15. Nourse MB, Halpin DE, Scatena M, et al. 2010; VEGF induces differentiation of functional endothelium from human embryonic stem cells: implications for tissue engineering. Arterioscler Thromb Vasc Biol 30: 80-89.
16. Oswald J, Boxberger S, Jorgensen B, et al. 2004; Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells 22: 377-384.
17. Pittenger MF, Mackay AM, Beck SC, et al. 1999; Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147.
18. Peister A, Mellad JA, Larson BL, et al. 2004; Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood 103: 1662-1668.
19. Prockop DJ. 1997; Marrow stromal cells as stem cells for non-hematopoietic tissues. Science 276: 71-74.
20. Reyes M, Dudek A, Jahagirdar B, et al. 2002; Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest 109: 337-346.
21. Roskoski R Jr. 2008; VEGF receptor protein-tyrosine kinases: structure and regulation. Biochem Biophys Res Commun 375: 287-291.
22. + lymphatic/vascular endothelial precursor cells. Blood 101: 168-172.
23. Toma C, Pittenger MF, Cahill KS, et al. 2002; Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105: 93-98.
24. Voyta JC, Via DP, Butterfield CE, et al. 1984; Identification and isolation of endothelial cells based on their increased uptake of acetylated-low density lipoprotein. J Cell Biol 99: 2034-2040.
25. Xu J, Liu X, Jiang Y, et al. 2008; MAPK/ERK signalling mediates VEGF-induced bone marrow stem cell differentiation into endothelial cell. J Cell Mol Med 12: 2395-2406.
26. Yamashita J, Itoh H, Hirashima M, et al. 2000; Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature 408: 92-96.
27. Zuk PA, Zhu M, Mizuno H, et al. 2001; Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7: 211-228.